oseltamivir has been researched along with Kidney Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabral, E; Carratalá, J; Cordero, E; Cruzado, JM; Delgado, JF; Gavaldá, J; Gómez-Bravo, MÁ; López-Medrano, F; Marcos, MÁ; Pérez-Romero, P; Sabé, N | 1 |
| Joo, KW; Kim, DK; Kim, M; Kim, S; Kim, YS; Lee, JP; Lee, JW; Lim, CS; Oh, KH; Shin, KH; Yu, KS | 1 |
| Doshi, P; Heneghan, CJ; Jefferson, T; Jones, M; Onakpoya, I; Spencer, EA | 1 |
| Brennan, BJ; Gibiansky, L; Giraudon, M; Kamal, MA; Rayner, CR; Robson, R; Subramoney, V | 1 |
| Brennan, BJ; Frey, N; Kamal, MA; Lien, YT; Morcos, PN; Rayner, CR; Subramoney, V | 1 |
| Sethi, SK | 1 |
| Chan, YH; Lau, PY; Ng, KH; Quak, ZX; Suhaila, M; Tambyah, PA; Tang, JW; Yap, HK | 1 |
2 review(s) available for oseltamivir and Kidney Diseases
| Article | Year |
|---|---|
Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Child; Cross Infection; Diagnosis, Differential; Disease Management; Drug Resistance, Viral; HN Protein; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Inpatients; Kidney Diseases; Organ Transplantation; Oseltamivir; Outpatients; Pneumonia; Postoperative Complications; Superinfection; Zanamivir | 2013 |
Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
Topics: Adult; Age Factors; Antiviral Agents; Child; Headache; Humans; Influenza, Human; Kidney Diseases; Nausea; Oseltamivir; Randomized Controlled Trials as Topic; Treatment Outcome; Vomiting | 2014 |
1 trial(s) available for oseltamivir and Kidney Diseases
| Article | Year |
|---|---|
Dose selection method for pharmacokinetic study in hemodialysis patients using a subpharmacological dose: oseltamivir as a model drug.
Topics: Computer Simulation; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Computer-Assisted; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Oseltamivir; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2014 |
4 other study(ies) available for oseltamivir and Kidney Diseases
| Article | Year |
|---|---|
Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairment.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Biological Availability; Female; Humans; Kidney Diseases; Male; Middle Aged; Models, Biological; Oseltamivir; Young Adult | 2015 |
Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Area Under Curve; Computer Simulation; Drug Administration Schedule; Female; Glycoside Hydrolase Inhibitors; Humans; Influenza, Human; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neuraminidase; Nonlinear Dynamics; Oseltamivir; Randomized Controlled Trials as Topic; Severity of Illness Index; Young Adult | 2015 |
H1N1 infection: a pediatric nephrologist's perspective.
Topics: Child; Child, Preschool; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Diseases; Oseltamivir | 2010 |
Benign clinical course in H1N1 2009 influenza infection in young oseltamivir-treated immunocompromised patients with kidney disease in Singapore.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Diseases; Male; Oseltamivir; Renal Dialysis; Singapore; Time Factors; Treatment Outcome; Virus Shedding; Young Adult | 2013 |